Back
Open Access

Time from first recorded clinical manifestation to diagnosis of transthyretin amyloid cardiomyopathy: a retrospective cohort study using US claims data

Session: From genetics to AI: advancing risk prediction and diagnosis in heart failure
Topic: Epidemiology, Prognosis, Outcome
Speaker: Associate Professor J. Mitchell (St Louis, US)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Joshua Mitchell

Washington University, St Louis (United States of America)
0 follower

5 more presentations in this session

Valvular heart disease and its association with mortality in advanced heart failure

Speaker: Doctor K. Steiger (Rochester, US)

Access
Abstract
Like
Thumbnail

Early clinical manifestations and time-to-diagnosis in patients with ATTR amyloidosis with mixed phenotype - results from the OverTTuRe study

Speaker: Doctor L. Anderson (London, GB)

Access
Abstract
Like
Thumbnail

Evaluating machine learning-based data extraction for heart failure management: a step toward optimized therapy

Speaker: Doctor J. Zmazek (Maribor, SI)

Access
Abstract
Like
Thumbnail

FINARM study versus FINE-HEART pooled analysis: comparative analysis of patients with heart failure and diabetic kidney disease

Speaker: Mr E. Boada Lincango (Las Palmas de Gran Canaria, ES)

Access
Abstract
Like
Thumbnail

Genome-wide association study of clinical outcomes in heart failure and Mendelian randomisation analysis of the impact of elevated body mass index on disease progression

Speaker: Doctor N. Sunderland (Bristol, GB)

Access
Abstract
Like
Thumbnail

Access the full session

From genetics to AI: advancing risk prediction and diagnosis in heart failure

Speakers: Associate Professor J. Mitchell, Doctor K. Steiger, Doctor L. Anderson, Doctor J. Zmazek, Mr E. Boada Lincango...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources